Navigation Links
NxStage to Present at UBS Global Life Sciences Conference
Date:9/8/2011

LAWRENCE, Mass., Sept. 8, 2011 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that Jeffrey H. Burbank, Chief Executive Officer, will present at the UBS Global Life Sciences Conference on Tuesday, September 20th, at 3:00 p.m. ET.   A webcast of the event will be made available at http://www.nxstage.com/ir.cfm at the time of the presentation.

(Logo: http://photos.prnewswire.com/prnh/20110503/MM94799LOGO)

About NxStage Medical

NxStage Medical, Inc. (Nasdaq: NXTM) is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative products for the treatment of end-stage renal disease, or ESRD, and acute kidney failure. For more information on NxStage and its products, please visit the company's website at http://www.nxstage.com.

Forward-Looking Statements

This release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this release that are not clearly historical in nature are forward-looking, and the words "anticipate," "believe," "expect," "estimate," "plan," and similar expressions are generally intended to identify forward-looking statements. Examples of these forward-looking statements include statements as to Mr. Burbank's plans to present at this conference.  NxStage specifically disclaims any obligation to update these forward-looking statements. These forward-looking statements should not be relied upon as representing NxStage's expectations or beliefs as of any date subsequent to the date of this press release.


'/>"/>
SOURCE NxStage Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. NxStage(R) to Recognize Several Key Milestones at American Society of Nephrologys Renal Week 2007
2. Boston Business Journal Names NxStage(R) Medical Third Fastest Growing Company in Massachusetts
3. NxStage(R) to Report Third Quarter 2009 Financial Results
4. NxStage(R) Reports Significant Interim FREEDOM Study Results
5. NxStage(R) and Nordic Medcom Sign Distribution Agreement for the System One(TM)
6. NxStage(R) Reports Third Quarter 2009 Financial Results and Raises Revenue Guidance for Fiscal 2009
7. Group of NxStage(R) Home Hemodialysis Patients to Take Caribbean Cruise with the System One(TM)
8. NxStage(R) Secures $15 Million Revolving Line of Credit
9. NxStage to Report Third Quarter Fiscal 2010 Financial Results
10. NxStage® Expands Product Portfolio With Innovative Patient Access Surveillance Solution From Vasc-Alert™
11. NxStage Announces Fourth Quarter 2010 Investor Conference Schedule
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... 30, 2015  Cleveland Clinic President Wael Barsoum ... last month that industry is compelled to adopt declining ... the efficiencies—and develop the transformational innovations -- required to ... were preceded by Doug Kohrs , past President ... who stressed that industry must add "episode of care," ...
(Date:7/30/2015)... 30, 2015 Future Market Insights ... "Continuous Glucose Monitoring Systems Market: Global Industry Analysis and ... the global continuous glucose monitoring systems market was valued ... to reach US$ 788.4 Mn by 2020, registering a ... 2020. Global continuous glucose monitoring systems market ...
(Date:7/30/2015)... Takeda Pharmaceutical Company Limited ("Takeda") today announced ... post-marketing commitment and submissions of data to regulatory ... Cancer Risk Characterization Study , a large (n= ... four European countries, for pioglitazone containing medicines, including ... of follow-up. Findings demonstrate that there is no ...
Breaking Medicine Technology:Orthopaedic Surgery Reimbursement Shifts to Episode of Care 2Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 2Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 3Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 4Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 2Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 3Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 4Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 5Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 6
... PDS Biotechnology Corporation today,announced that the company ... the US,National Cancer Institute,s Nanotechnology Characterization Lab ... to filing of,the Investigational New Drug Application. ... biological studies on behalf of the company ...
... Dendreon Corporation (Nasdaq:,DNDN) today will present a summary ... investigational active cellular immunotherapy, at the,Chemotherapy Foundation Symposium ... data from two clinical trials, highlights the safety,profile, ... patients with,HER2/neu-positive cancer who have failed standard therapy., ...
Cached Medicine Technology:PDS Biotechnology Corporation Progresses Development of Nanotechnology Cancer Therapies 2Dendreon Presents Integrated Analysis of Clinical Data from NEUVENGE Trials at Chemotherapy Foundation Symposium 2Dendreon Presents Integrated Analysis of Clinical Data from NEUVENGE Trials at Chemotherapy Foundation Symposium 3Dendreon Presents Integrated Analysis of Clinical Data from NEUVENGE Trials at Chemotherapy Foundation Symposium 4
(Date:7/31/2015)... ... 2015 , ... Super-Sod wants to participate in planning new home lawns from ... the perfect fit for such a goal. Houzz is a social media site that ... dynamic site that spreads home and home garden design ideas when members share their ...
(Date:7/31/2015)... ... 2015 , ... India Network Foundation sponsors visitor health insurance program ... visit for the past 25 years. As India Network offers coverage for all age ... spend time with their children and grand children. India Network specializes in covering ...
(Date:7/31/2015)... ... July 31, 2015 , ... With the recent buzz surrounding ... who remain undiagnosed, treatment options for patients are becoming more prevalent than ever ... due to its overall lack of comfort and highly invasive nature, oral appliances ...
(Date:7/30/2015)... Islands, BWI (PRWEB) , ... July 31, 2015 , ... The Venetian on Grace Bay ... 2015. Guests who stay at the Venetian will save 40% on their stay while ... months are always quiet in the Turks & Caicos, providing a chance to reconnect with ...
(Date:7/30/2015)... ... July 30, 2015 , ... As more hospitals across the country see the ... a serious challenge. Because of growing competition, it is more important than ever ... , The team at Wound Care Advantage has found that while ...
Breaking Medicine News(10 mins):Health News:Super-Sod Created a Landscape Profile on Houzz.com for Home Garden Design 2Health News:India Network Visitor Health Insurance Announces Completion of Food Grains Distribution to Godavari Pushkaram Visitors, Andhra Pradesh, India 2Health News:India Network Visitor Health Insurance Announces Completion of Food Grains Distribution to Godavari Pushkaram Visitors, Andhra Pradesh, India 3Health News:Oravan Sleep Apnea Device Gains Traction in Sleep Industry 2Health News:The Venetian on Grace Bay in Turks & Caicos Islands Offers 40% Savings This Fall. 2Health News:WCA Offers Shockwave; The Marketing Module for Hospital Wound Care Programs 2Health News:WCA Offers Shockwave; The Marketing Module for Hospital Wound Care Programs 3Health News:WCA Offers Shockwave; The Marketing Module for Hospital Wound Care Programs 4
... life, chronic diseases and other health problems tend to accumulate ... in the latest issue of The Journal of Gerontology: Medical ... to the presence of coexisting medical conditions - known as ... articles on the topic. ,New diagnoses of common ...
... recent study finds that stents do not prevent heart ... minimize chest pains and to prevent heart attacks//. Stents ... keep them open. ,This landmark study funded ... stents do improve blood flow but are no more ...
... for its abundant health benefits. Now, British scientists, armed ... of a vital element in green tea, which may ... in the Journal of Allergy and Clinical Immunology. ... discovered that an important element in green tea called ...
... has shown the increase in the number of licenses ... Physicians// and Surgeons- 42 per cent of the 2,961 ... graduates. ,Among the foreign-trained doctors who received ... the rest were enabled education licenses or positions for ...
... the Federal Government’s decision to include the rotavirus vaccine // ... past year, the AMA has been calling for the Government ... at risk of contracting the deadly disease, so we’re very ... Australian babies,” Dr Haikerwal said. ,“Rotavirus is ...
... The killer or killers of cricket coach Bob Woolmer used ... absence of any marks on his neck, newspaper reports from ... introducing many modern techniques in coaching, was found unconscious in ... less than 24 hours after Pakistan was knocked out of ...
Cached Medicine News:Health News:Stents Do Little to Prevent Heart Attacks 2Health News:Bob Woolmer Was Strangled With A Towel 2
... IMMULITE 2500 is a high-throughput immunoassay system ... the IMMULITE 2000 with the important addition ... ,allows assays to be designed for optimal ... ,This allows for critical assays such as ...
The Acute Care myoglobin method is an in vitro diagnostic test for the measurement of myoglobin in heparinized whole blood /plasma. Myoglobin measurements can be used as an aid in diagnosing myocardi...
... Today's three preferred cardiac markers ... Aio! immunoassay system. Cardiac Troponin ... with very high sensitivity and ... Myoglobin appears very soon following ...
... the quantitative determination of myoglobin concentration in ... test is based on the principle of ... assay system utilizes a unique monoclonal antibody ... the myoglobin molecule. Mouse monoclonal anti-myoglobin antibody ...
Medicine Products: